Related Experiment Video
Updated: Jan 21, 2026
07:26
Studying Left Ventricular Reverse Remodeling by Aortic Debanding in Rodents
Published on: July 14, 2021
5.5K
Unresolved issues in left ventricular postischemic remodeling and progression to heart failure
Edoardo Gronda1, Stefania Sacchi2, Giuditta Benincasa3,4
1Cardiovascular Department Multimedica, IRCCS.
Journal of Cardiovascular Medicine (Hagerstown, Md.)
|July 26, 2019
Summary
Coronary reperfusion therapy reduces heart attack deaths but increases heart failure. Understanding post-heart attack cardiac biology is key to preventing heart failure and improving patient outcomes.
Area of Science:
- Cardiology
- Molecular Biology
- Pathophysiology
Background:
- Coronary reperfusion therapy has decreased myocardial infarction mortality.
- However, there's an observed increase in new-onset heart failure post-myocardial infarction.
- Current practices aggregate heart failure types, obscuring complex post-ischemic cardiac biology.
Purpose of the Study:
- To investigate the complex mechanisms underlying heart failure following myocardial infarction.
- To explore factors contributing to adverse cardiac remodeling and long-term heart failure.
- To review current and future therapeutic strategies and diagnostic tools.
Main Methods:
- Focused on myocyte loss, hypertrophy, hyperplasia, and extracellular matrix changes.
- Examined metabolic imbalances and immunologic responses in the acute aftermath.
- Discussed cardiac magnetic resonance as a diagnostic tool.
Main Results:
- Identified multiple factors contributing to long-term adverse cardiac remodeling post-ischemia.
- Highlighted the role of myocyte alterations, fibrosis, metabolic shifts, and immune responses.
- Cardiac magnetic resonance shows promise for quantifying myocardial damage.
Conclusions:
- Post-ischemic cardiac biology involves complex repair and compensation mechanisms leading to adverse remodeling.
- A deeper understanding of these multifaceted pathogenic mechanisms is crucial for customized patient management.
- Future research should focus on elucidating specific contributions to the heart failure phenotype.
More Related Videos
09:37Permanent Ligation of the Left Anterior Descending Coronary Artery in Mice: A Model of Post-myocardial Infarction Remodelling and Heart Failure
Published on: December 2, 2014
28.6K
07:13A Rat Model of Pressure Overload Induced Moderate Remodeling and Systolic Dysfunction as Opposed to Overt Systolic Heart Failure
Published on: April 30, 2020
6.9K
Related Concept Videos
01:29Heart Failure II: Pathophysiology
783
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
783
01:17Pathophysiology of Heart Failure
3.0K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
3.0K
01:27Heart Failure I: Introduction
723
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
723
01:22Heart Failure VI: Adjunct Therapies
277
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
277
01:22Heart Failure Drugs: Diuretics
824
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
824
01:30Heart Failure V: Medical Management
227
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
227